hydrocodone bitartrate and chlorpheniramine maleate solution
acella pharmaceuticals, llc - hydrocodone bitartrate (unii: no70w886kk) (hydrocodone - unii:6yks4y3wq7), chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u) - hydrocodone bitartrate 5 mg in 5 ml - hydrocodone bitartrate and chlorpheniramine maleate oral solution is indicated for relief of cough and symptoms associated with upper respiratory allergies or a common cold in adults 18 years of age and older. important limitations of use not indicated for pediatric patients under 18 years of age [see use in specific populations ( 8.4)] . hydrocodone bitartrate and chlorpheniramine maleate oral solution is contraindicated in: - patients with known hypersensitivity to hydrocodone bitartrate, chlorpheniramine maleate or any of the inactive ingredients of hydrocodone bitartrate and chlorpheniramine maleate oral solution. - patients receiving maoi therapy or within 14 days of stopping such therapy. - patients with narrow angle glaucoma, urinary retention, severe hypertension, or severe coronary artery disease. teratogenic effects: pregnancy category c there are no adequate and well-controlled studies of hydrocodone bitartrate and chlorpheniramine maleate oral solut
hydrocodone polistirex and chlorpheniramine polistirex suspension, extended release
neos therapeutics lp - hydrocodone (unii: 6yks4y3wq7) (hydrocodone - unii:6yks4y3wq7), chlorpheniramine (unii: 3u6io1965u) (chlorpheniramine - unii:3u6io1965u) - hydrocodone 10 mg in 5 ml - hydrocodone polistirex and chlorpheniramine polistirex extended-release oral suspension extended-release suspension is indicated for the temporary relief of cough and upper respiratory symptoms associated with allergy or the common cold in patients 18 years of age and older. important limitations of use: - not indicated for pediatric patients under 18 years of age [ see use in specific populations (8.4) ]. - contraindicated in pediatric patients less than 6 years of age [ see contraindications (4) ]. - because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [ see warnings and precautions (5.1) ] , reserve hydrocodone polistirex and chlorpheniramine polistirex extended-release oral suspension for use in adult patients for whom the benefits of cough suppression are expected to outweigh the risks, and in whom an adequate assessment of the etiology of the cough
pharmaniaga chlorpheniramine tablet 4mg
pharmaniaga manufacturing berhad - chlorpheniramine maleate -
dexchlorpheniramine maleate, phenylephrine hcl tablet
syntho pharmaceuticals inc. - phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv), dexchlorpheniramine maleate (unii: b10yd955qw) (dexchlorpheniramine - unii:3q9q0b929n) - - dexchlorpheniramine maleate 2 mg - antihistamine - phenylephrine hcl 10 mg - nasal decongestant temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies: ■ runny nose ■ sneezing ■ itching of the nose or throat ■ itchy, watery eyes ■ nasal congestion ■ reduces swelling of nasal passages
canex 15ml dps
esken - chlorpheniramine maleate,phenylpropanolamine hcl. - dps - 2,12.5;mg/5ml - 15ml
chemonic 60ml syr
chemo d. - chlorpheniramine maleate,phenylpropanolamine hcl. - syr - 2,12.5mg/5ml - 60ml
chericold 10 cap
ranbaxy - chlorpheniramine maleate,phenylpropanolamine hcl. - cap - 8,50;mg ;tr - 10
cofdex 100ml f. exp
cipla - chlorpheniramine maleate,phenylpropanolamine hcl.,bromhexine hcl. - f. exp - 2,12.5,4;mg/5ml - 100ml
coldact 15ml dps
sun - chlorpheniramine maleate,phenylpropanolamine hcl. - dps - 2,10;mg/ml - 15ml
coldact 60ml syr
sun - chlorpheniramine maleate,phenylpropanolamine hcl. - syr - 2,10;mg/5ml - 60ml